Edit Szodorai is a European Patent Attorney in the Life Science and Chemistry team at the Stockholm office. Edit supports clients mainly in the area of biologics and small molecule pharmaceuticals, antibodies and protein engineering, vaccine development as well as advanced cell and gene therapies (ATMPs).

Her expert assistance involves patentability assessment, drafting and prosecution of patent applications, patent landscape analysis and competitor monitoring, IP strategy, IP due diligence and FTO analysis. She is engaged in the assessment of patentability and FTO, relying on complex sequence analysis of therapeutic antibodies and nucleic acid therapeutics.